Whalesbook
Ab paisa banega, bas revenue nahi!
Company ne business ko run karne ka tareeka badal diya hai. Ab sirf sales badhane ki race mein nahi hain, balki cost ko control karke profit nikal rahe hain. Diagnostics business ne toh ₹600 Crore ka annualized revenue run rate cross kar liya hai. High-volume testing ke saath specialised services ko mix karke, ye log online pharmacy ke price war se bach rahe hain.
Physical Stores ka power!
Online pharmacies ke opposite, Tata 1mg ne 500 locations tak physical stores khol liye hain. Isse unko high customer acquisition cost ki problem nahi ho rahi. Ye physical labs patient ko connect karne aur repeat business ke liye perfect hain. Is omnichannel strategy se company medication sales aur diagnostic services dono ka faida utha rahi hai.
Risk bhi hai, bhai!
Bhale hi profit ho raha hai, par 280 se zyada physical stores kholne mein paisa lagta hai, jisse fixed costs badh jaati hain. Plus, quick-commerce waali companies bhi pharmacy mein enter kar rahi hain, jo price war chhed sakti hain. Aur haan, India mein digital health regulations bhi change ho rahe hain, jisse data privacy aur online prescription par asar pad sakta hai.
Data se banega future!
Next year, Tata 1mg apna AI platform 'Pulse' use karegi B2B partners ke liye. Target hai ki marketplace se data-driven service provider banein, taaki low-margin sales par dependency kam ho. Preventive care aur family health analytics par focus karke, company average revenue per user badhana chahti hai.